Načítá se...

The MYCN-HMGA2-CDKN2A pathway in non-small cell lung carcinoma—differences in histological subtypes

BACKGROUND: Extensive research has increased our understanding of the molecular alterations needed for non-small cell lung cancer (NSCLC) development. Deregulation of a pathway including MYCN, HMGA2 and CDKN2A, with the participation of DICER1, is of importance in several solid tumours, and may also...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMC Cancer
Hlavní autoři: Eide, Hanne A., Halvorsen, Ann Rita, Bjaanæs, Maria Moksnes, Piri, Hossein, Holm, Ruth, Solberg, Steinar, Jørgensen, Lars, Brustugun, Odd Terje, Kiserud, Cecilie Essholt, Helland, Åslaug
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2016
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4746877/
https://ncbi.nlm.nih.gov/pubmed/26858029
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-016-2104-9
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!